Articles with public access mandates - Tora S SolheimLearn more
Available somewhere: 12
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
TS Solheim, BJA Laird, TR Balstad, A Bye, G Stene, V Baracos, F Strasser, ...
BMJ supportive & palliative care 8 (3), 258-265, 2018
Mandates: Cancer Research UK, Marie Curie Cancer Care, UK, National Institute for …
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
N Johns, C Stretch, BHL Tan, TS Solheim, S Sørhaug, NA Stephens, ...
Journal of cachexia, sarcopenia and muscle 8 (1), 122-130, 2017
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
P‐selectin genotype is associated with the development of cancer cachexia
BHL Tan, T Fladvad, TP Braun, A Vigano, F Strasser, DAC Deans, ...
EMBO molecular medicine 4 (6), 462-471, 2012
Mandates: US National Institutes of Health
Deterioration in muscle mass and physical function differs according to weight loss history in cancer cachexia
GB Stene, TR Balstad, ASM Leer, A Bye, S Kaasa, M Fallon, B Laird, ...
Cancers 11 (12), 1925, 2019
Mandates: National Institute for Health Research, UK
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
J McDonald, J Sayers, SD Anker, J Arends, TR Balstad, V Baracos, ...
Journal of cachexia, sarcopenia and muscle 14 (5), 1932-1948, 2023
Mandates: Cancer Research UK, National Institute for Health Research, UK
Food intake by Patient-Generated Subjective Global Assessment (PG-SGA) corresponds to energy and protein intake as well as weight change in patients with advanced cancer
A Bye, K Meli, TS Solheim, B Laird, S Kaasa, GB Stene, TR Balstad
Clinical Nutrition Experimental 25, 20-28, 2019
Mandates: Cancer Research UK
Power comparisons and clinical meaning of outcome measures in assessing treatment effect in cancer cachexia: secondary analysis from a randomized pilot multimodal intervention …
TR Balstad, C Brunelli, CH Pettersen, SA Schønberg, F Skorpen, M Fallon, ...
Frontiers in nutrition 7, 602775, 2021
Mandates: Cancer Research UK
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
OM Vagnildhaug, TR Balstad, I Ottestad, A Bye, C Greil, J Arends, ...
Journal of Cachexia, Sarcopenia and Muscle 15 (2), 513-535, 2024
Mandates: Cancer Research UK, National Institute for Health Research, UK
Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to …
TS Solheim, BJA Laird, TR Balstad, GB Stene, V Baracos, A Bye, O Dajani, ...
Journal of Clinical Oncology 42 (17_suppl), LBA12007-LBA12007, 2024
Mandates: World Cancer Researh Fund, UK
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
MS Yule, J Thompson, K Leesahatsawat, MS Sousa, SD Anker, J Arends, ...
Journal of Cachexia, Sarcopenia and Muscle, 2024
Mandates: Cancer Research UK, National Institute for Health Research, UK
Do older patients with colorectal cancer experience more deterioration in health-related quality of life than younger patients during the first year of palliative chemotherapy …
I Hatlevoll, AK Kristensen, TS Solheim, H Elvebakken, Ø Salvesen, ...
Journal of Geriatric Oncology 15 (3), 101715, 2024
Mandates: Dam Foundation, Norway
Do elderly colorectal cancer patients experience more deterioration in health-related quality of life during the first year of palliative chemotherapy?–A prospective real-world …
I Hatlevoll, AK Kristensen, TS Solheim, H Elvebakken, Ø Salvesen, ...
Mandates: Dam Foundation, Norway
Publication and funding information is determined automatically by a computer program